BENIDIPINE in pharma franchise in West Bengal

BENIDIPINE in PCD pharma franchise in Raipur

BENIDIPINE in top pharma company in Aizawl

BENIDIPINE in pcd pharma supplier in Kohima

BENIDIPINE in phama franchise company in india
BENIDIPINE in phama distributor in Ranchi

Home/Products /benidipine-4-mg-tablet

Beniflip 4 Tablet

Composition : Benidipine 4mg Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹96/-

Beniflip 4 Tablet contains Benidipine 4 mg, a calcium channel blocker (CCB) primarily used for managing hypertension (high blood pressure) and certain cardiovascular conditions. Benidipine works by relaxing blood vessels, improving blood flow, and reducing the strain on the heart. This leads to lower blood pressure and a decreased risk of heart-related complications, such as strokes and heart attacks.

Unlike other calcium channel blockers, Benidipine has a longer duration of action, ensuring sustained blood pressure control throughout the day. It also exhibits protective effects on the kidneys and heart, making it particularly beneficial for patients with hypertension-related complications, diabetes, or chronic kidney disease.

Additionally, Benidipine has vasodilatory effects, meaning it helps improve circulation and reduce chest pain (angina) in patients with coronary artery disease. By enhancing oxygen delivery to the heart muscle, it alleviates episodes of chest discomfort and supports overall cardiovascular health.

Beniflip 4 Tablet is well-tolerated by most patients and can be used as a standalone treatment or in combination with other antihypertensive medications. It is essential to take this medication as directed by a healthcare professional to achieve optimal results.

Read More

About the Product

Beniflip 4 Tablet contains Benidipine 4 mg, a calcium channel blocker (CCB) primarily used for managing hypertension (high blood pressure) and certain cardiovascular conditions. Benidipine works by relaxing blood vessels, improving blood flow, and reducing the strain on the heart. This leads to lower blood pressure and a decreased risk of heart-related complications, such as strokes and heart attacks.

Unlike other calcium channel blockers, Benidipine has a longer duration of action, ensuring sustained blood pressure control throughout the day. It also exhibits protective effects on the kidneys and heart, making it particularly beneficial for patients with hypertension-related complications, diabetes, or chronic kidney disease.

Additionally, Benidipine has vasodilatory effects, meaning it helps improve circulation and reduce chest pain (angina) in patients with coronary artery disease. By enhancing oxygen delivery to the heart muscle, it alleviates episodes of chest discomfort and supports overall cardiovascular health.

Beniflip 4 Tablet is well-tolerated by most patients and can be used as a standalone treatment or in combination with other antihypertensive medications. It is essential to take this medication as directed by a healthcare professional to achieve optimal results.

Common side effects may include dizziness, headache, flushing, swelling in the legs, and palpitations. Serious side effects are rare but may include excessive hypotension or allergic reactions.

Used for the treatment of hypertension (high blood pressure) and angina (chest pain) in cardiovascular conditions.

Should be taken under medical supervision. Do not discontinue abruptly. Patients with severe liver or kidney conditions should consult their doctor before use.

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation